Page 1 of Clinical Trials for Drug Sorafenib Escalated Dose, 11 Total Matches
- 1TerminatedLast Updated: August 18, 2011Condition(s): Renal Cell Carcinoma
- 2Active, not recruitingLast Updated: December 31, 2009Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
- 3Not yet recruitingLast Updated: May 23, 2012Condition(s): Breast Neoplasms
- 4RecruitingLast Updated: December 14, 2011Condition(s): Liver Carcinoma
- 5RecruitingLast Updated: March 26, 2009Condition(s): Non-Small Cell Lung Cancer
- 6Active, not recruitingLast Updated: March 15, 2011Condition(s): Neoplasms
- 7CompletedLast Updated: January 30, 2009Condition(s): Carcinoma, Renal Cell
- 8Active, not recruitingLast Updated: October 27, 2010Condition(s): Neuroendocrine Tumors
- 9Active, not recruitingLast Updated: January 10, 2012Condition(s): Brain Metastases; Primary Brain Tumors
- 10TerminatedLast Updated: April 28, 2011Condition(s): Ovarian Cancer
- 11Active, not recruitingLast Updated: April 26, 2012Condition(s): Pulmonary Arterial Hypertension
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Sorafenib+Escalated+Dose
